Last reviewed · How we verify

NCT02913352

Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation

Recruiting now NA Last updated 29 January 2026
What this trial tests

NA trial testing Latarjet procedure in Shoulder Dislocation in 60 participants. Currently enrolling.

Timeline
1 September 2016
Primary endpoint
1 December 2027
1 December 2029

Quick facts

Lead sponsorUniversity of Sao Paulo
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 September 2016
Primary completion1 December 2027
Estimated completion1 December 2029
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

16 and older, any sex, with Shoulder Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shoulder Dislocation

Currently open trials in the same condition.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02913352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing